MAA
ACHN

Managed Account Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Managed Account Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-141
Closed -$1K – 3164
2015
Q1 		$1K Sell
141
-49
-26% -$612 ﹤0.01% 2939
2014
Q4 		$2K Buy
+190
New +$2.32K ﹤0.01% 2693
2013
Q4 		– Sell
-1,163
Closed -$4K – 2609
2013
Q3 		$4K Sell
1,163
-126,326
-99% -$866K ﹤0.01% 2460
2013
Q2 		$1.04M Buy
+127,489
New +$973K ﹤0.01% 1857

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Managed Account Advisors's ACHN Position: Q2 2015 in Review

Managed Account Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q2 2015, closing a stake of 141 shares — an estimated $1K sold.

Managed Account Advisors first reported a position in ACHN in Q2 2013 and held it in 4 quarters. The position peaked at $1.04M in Q2 2013. 158 funds tracked by Wall St. Rank hold ACHN as of Q2 2015.

  • Managed Account Advisors reported no remaining Achillion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Managed Account Advisors sold 141 Achillion Pharmaceuticals shares in Q2 2015, an estimated $1K.
  • Managed Account Advisors first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Managed Account Advisors's Achillion Pharmaceuticals position peaked at $1.04M in Q2 2013.
  • 158 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.